×
Innoviva SG&A Expenses 2010-2024 | INVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Innoviva sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
Innoviva SG&A Expenses 2010-2024 | INVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Innoviva sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$692.7B
Novo Nordisk (NVO)
$460.6B
Johnson & Johnson (JNJ)
$368.4B
AbbVie (ABBV)
$294.4B
Merck (MRK)
$244.2B
Novartis AG (NVS)
$211.1B
AstraZeneca (AZN)
$197.8B
Pfizer (PFE)
$142.2B
Sanofi (SNY)
$121.8B